Corticobasal Degeneration and Corticobasal Syndrome


Quick Start: Corticobasal Degeneration And Corticobasal Syndrome

Definition
  • Corticobasal degeneration is a neurodegenerative disease of the brain caused by accumulation of hyperphosphorylated 4-repeat tau isoforms.

  • Corticobasal syndrome is a clinical diagnosis characterized by asymmetric cortical dysfunction, which may include difficulties with motor control of a limb (apraxia), executive dysfunction, nonfluent aphasia, speech disruption, rigidity, a jerky postural tremor, myoclonus, dystonia, and a gait disorder.

  • Not all patients with corticobasal syndrome have underlying corticobasal degeneration pathology, and not all patients with corticobasal degeneration pathology present with corticobasal syndrome.

Prevalence
  • It is a relatively rare disorder, with the prevalence being about 2 per 100,000.

  • The age of onset ranges from 45 to 77 (mean 64) years, with a disease duration of 2 to 12.5 (mean 6.6) years.

Cognitive, behavioral, and motor signs and symptoms
  • Focal and asymmetric signs and symptoms are the cardinal features of corticobasal degeneration, including asymmetric apraxia, myoclonus, dystonia, cortical sensory loss, and unilateral visual or sensory neglect.

  • An “alien limb”—a limb with “a mind of its own”—is a pathognomonic but uncommon sign. A “useless limb” not able to participate in functional activities is common.

  • Speech may be disrupted owing to apraxia or nonfluent aphasia.

  • Cognitive testing demonstrates frontal and parietal cognitive dysfunction with relative preservation of recognition memory.

Summary of diagnostic clinical research criteria for probable sporadic corticobasal degeneration (see text for details)
  • Insidious onset and gradual progression of at least one year.

  • Clinical phenotypes of one of the following:

    • Probable corticobasal syndrome:

      • Asymmetric presentation of two of the following:

        • a.

          limb rigidity or akinesia

        • b.

          limb dystonia

        • c.

          limb myoclonus

      • plus two of:

        • d.

          orobuccal or limb apraxia

        • e.

          cortical sensory deficit

        • f.

          alien limb phenomena

    • Frontal behavioral-spatial syndrome:

      • Two of:

        • a.

          executive dysfunction

        • b.

          behavioral or personality changes

        • c.

          visuospatial deficits

      • plus at least one corticobasal feature (a–f, above)

    • Nonfluent/agrammatic variant of primary progressive aphasia

      • Effortful, agrammatic speech plus at least one of:

        • a.

          impaired grammar/sentence comprehension with relatively preserved single word comprehension

        • b.

          groping, distorted speech production (apraxia of speech)

      • plus at least one corticobasal feature (a–f, above)

  • Exclusion criteria: evidence of other neurological disorder that could explain signs and symptoms.

Treatment
  • There are no U.S. Food and Drug Administration-approved medications to treat corticobasal degeneration; treatment is supportive.

  • Antidepressants should be used to treat depression, which is often present.

  • Dystonia may be relieved with botulinum toxin.

  • Physical and occupational therapy is important for range of motion in affected limbs so that contractures do not develop.

Top differential diagnoses
  • Frontotemporal dementia, primary progressive aphasia or apraxia of speech, progressive supranuclear palsy, dementia with Lewy bodies, Alzheimer’s disease, vascular dementia.

A 73-year-old woman was brought in by her daughter for functional decline. The patient did not notice anything wrong. Per her daughter, memory problems were prominent, but there was also trouble with her movements. Her daughter noted that she did not have control of the left hand or foot; they had “a mind of their own.” She reported that these difficulties came out when her mother dressed and undressed, and when she ate using utensils; she was unable to cut up anything. On examination a paucity of spontaneous speech was evident. She had almost continuous myoclonus and asterixis evident in both upper extremities, which her family described as “shaking” and another clinician described as “tremor.” She veered off to the left when walking and sometimes bumped into the hallway wall. She did not use the left hand spontaneously. She attempted to untie her shoes with her right hand only—the left hand stayed gripping the arm of the chair. She demonstrated multiple apraxias, all worse with the left hand, including an inability to pantomime use of objects such as a comb or a knife, which improved markedly when imitating the examiner or using the actual object. She was unable to identify coins placed in either hand or identify any number (except 1) drawn in either hand.

Prevalence, Prognosis, and Definition

Corticobasal degeneration is a neurodegenerative disease of the brain caused by the accumulation of hyperphosphorylated 4-repeat tau isoforms. Corticobasal syndrome is a clinical diagnosis characterized by asymmetric cortical dysfunction, often affecting motor control of a limb, along with executive dysfunction, rigidity, a jerky postural tremor, myoclonus, dystonia, and a gait disorder; speech may be disrupted owing to apraxia or nonfluent aphasia. We now recognize that not all patients with corticobasal syndrome have underlying corticobasal degeneration pathology, and not all patients with corticobasal degeneration pathology present with corticobasal syndrome ( ); see Chapter 3 for a more general discussion of the issue of separating degenerative diseases from dementia syndromes. Corticobasal degeneration is a relatively rare disorder with a prevalence of about 2 per 100,000. From one literature review, the mean age of onset was 64 years, ranging from 45 to 77 years, with an average prognosis from diagnosis to death of about 6.6 years, ranging from 2 to 12.5 years ( ).

Criteria

Based on the clinical phenotypes of 129 autopsy-proven cases, a 2013 paper presented two sets of criteria for corticobasal degeneration: more specific clinical research criteria for sporadic probable corticobasal degeneration and broader, more inclusive criteria for possible corticobasal degeneration that may overlap with other tau-based pathologies ( Table 13.1 ) ( ). Both criteria are based on five clinical phenotypes that have been proven to be associated with the pathology of corticobasal degeneration ( Table 13.2 ). Definitions and explanations for many of the terms used in these criteria can be found in the Common Signs, Symptoms, and Stages section. Unfortunately, studies have found that these criteria are not highly sensitive or specific ( ).

Table 13.1
Diagnostic Criteria for Corticobasal Degeneration
Modified from Armstrong, M. J., Litvan, I., Lang, A. E., et al. (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology, 80 , 496–503.
Clinical Research Criteria for Probable Sporadic Corticobasal Degeneration Clinical Criteria for Possible Corticobasal Degeneration
Presentation Insidious onset and gradual progression Insidious onset and gradual progression
Minimum duration of symptoms 1 year 1 year
Age at onset ≥50 years No minimum
Family history (≥2 or more relatives) Exclusion Permitted
Permitted phenotypes (see Table 13.2 )
  • 1.

    Probable corticobasal syndrome

    or

  • 2.

    Frontal behavioral-spatial syndrome plus at least one corticobasal feature (a–f in Table 13.2 )

    or

  • 3.

    Nonfluent/agrammatic variant of primary progressive aphasia plus at least one corticobasal feature (a–f in Table 13.2 )

  • 1.

    Possible corticobasal syndrome

    or

  • 2.

    Frontal behavioral-spatial syndrome

    or

  • 3.

    Nonfluent/agrammatic variant of primary progressive aphasia

    or

  • 4.

    Progressive supranuclear palsy syndrome plus at least one corticobasal feature (b–f in Table 13.2 )

Genetic mutation affecting tau (e.g., microtubule-associated protein tau) Exclusion Permitted
Exclusion criteria (same for both)
  • 1.

    Evidence of Lewy body disease: classic 4-Hz Parkinson disease resting tremor, excellent and sustained levodopa response, or hallucinations.

  • 2.

    Evidence of multiple system atrophy: dysautonomia or prominent cerebellar signs.

  • 3.

    Evidence of amyotrophic lateral sclerosis: presence of both upper and lower motor neuron signs.

  • 4.

    Semantic- or logopenic-variant primary progressive aphasia.

  • 5.

    Structural lesion suggestive of focal cause.

  • 6.

    Granulin mutation or reduced plasma progranulin levels; TDP-43 mutations; fused in sarcoma mutations.

  • 7.

    Evidence of Alzheimer’s disease (this will exclude approximately 14% of cases of corticobasal degeneration with coexisting amyloid): laboratory findings strongly suggestive of Alzheimer’s disease such as low cerebral spinal fluid Aβ42 to tau ratio or positive amyloid positron emission tomography, or genetic mutation suggesting Alzheimer’s disease (e.g., presenilin, amyloid precursor protein).

Table 13.2
Clinical Phenotypes Associated With the Pathology of Corticobasal Degeneration
Modified from Armstrong, M. J., Litvan, I., Lang, A. E., et al. (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology, 80 , 496–503.
Probable corticobasal syndrome Asymmetric presentation of two of:

  • a.

    limb rigidity or akinesia

  • b.

    limb dystonia

  • c.

    limb myoclonus

plus two of:

  • d.

    orobuccal or limb apraxia

  • e.

    cortical sensory deficit

  • f.

    alien limb phenomena (more than simple levitation)

Possible corticobasal syndrome May be symmetric: one of:

  • a.

    limb rigidity or akinesia

  • b.

    limb dystonia

  • c.

    limb myoclonus

plus one of:

  • d.

    orobuccal or limb apraxia

  • e.

    cortical sensory deficit

  • f.

    alien limb phenomena (more than simple levitation)

Frontal behavioral-spatial syndrome Two of:

  • a.

    executive dysfunction

  • b.

    behavioral or personality changes

  • c.

    visuospatial deficits

Nonfluent/agrammatic variant of primary progressive aphasia Effortful, agrammatic speech plus at least one of:

  • a.

    impaired grammar/sentence comprehension with relatively preserved single word comprehension

  • b.

    groping, distorted speech production (apraxia of speech)

Progressive supranuclear palsy syndrome Three of:

  • a.

    axial or symmetric limb rigidity or akinesia

  • b.

    postural instability or falls

  • c.

    urinary incontinence

  • d.

    behavioral changes

  • e.

    supranuclear vertical gaze palsy or decreased velocity of vertical saccades (see Chapter 12 for description)

It is worth noting that one of the clinical phenotypes associated with corticobasal degeneration is “progressive supranuclear palsy syndrome.” That this syndrome is one of the clinical phenotypes does not mean that progressive supranuclear palsy is a subset of corticobasal degeneration or that the two disorders are really the same. It does mean that some patients with underlying corticobasal degeneration pathology look very similar to patients with underlying progressive supranuclear palsy pathology.

Risk Factors, Pathology, and Pathophysiology

There are no known risk factors for developing corticobasal degeneration. A characteristic of this disorder is that the distribution of pathology and atrophy is asymmetric. Cortical regions affected are around the main sulci of the brain: parasagittal, peri-Rolandic, and peri-Sylvian. Subcortical structures affected include substantia nigra, and variably the globus pallidus, subthalamic nucleus, and thalamus. Under the microscope, the pathology consists of swollen achromatic neurons in amygdala and limbic structures, as well as ballooned neocortical achromatic neurons in specific layers (III, V, and VI) in frontal and parietal lobes ( Fig. 13.1 ). Hippocampal and temporal lobe regions are least affected. Corticobasal degeneration is associated with the accumulation of hyperphosphorylated 4-repeat tau protein isoforms in neurons and glia.

Fig. 13.1, Pathology of corticobasal degeneration. (A) Atrophy of the frontal lobe. (B) Swollen and ballooned achromatic neurons. (C) Astrocytic plaques.

Common Signs, Symptoms, and Stages

Corticobasal syndrome classically starts with an impaired limb, which may present as an “alien limb,” but more often it presents as a stiff, clumsy, and useless hand. Retrospective autopsy studies show, however, that more patients actually present with cognitive, speech, behavioral, or gait abnormalities than those who present with limb abnormalities. Limb abnormalities are likely relatively specific for corticobasal degeneration but are not sensitive enough to allow one to rely upon this sign to detect the disorder. Presenting and early symptoms may include the following:

  • Alien limb (not common but pathognomonic when it occurs): The affected limb is described as “having a mind of its own,” and patients report having little or no control over it. It may grasp, grope, wander, or take hold of objects, clothes, and people. Occasionally it may interfere with the function of the unaffected limb.

  • Useless limb (common): The limb is not able to participate in functional activities, often because of varying combinations of rigidity, akinesia, dystonia, myoclonus, and apraxia.

  • Focal/limb apraxias: Inability to perform skilled and/or learned movements unexplained by abnormalities such as weakness, incoordination, language difficulties, and so on. See Box 13.1 and , , .

    Box 13.1
    Apraxia (see , ,
    )

    A patient is said to have an apraxia when he or she is unable to perform a purposeful, coordinated movement despite normal strength and sensation. The patient’s actions often appear clumsy and uncoordinated. Apraxias come in a variety of types. Some of the more common are as follows.

    • Limb-kinetic apraxia refers to the loss of the ability to make precise independent finger movements, such as the pincer grasp that is needed to pick up a small coin off a flat surface.

    • Patients with ideomotor apraxia make errors in spatial movement, orientation, and/or timing of previously learned skilled movements. For example, when pantomiming cutting paper with scissors, he or she may not keep the scissors correctly oriented to the paper.

    • In conduction apraxia, patients show more difficulty imitating a skilled movement (such as a salute) than performing the movement to command.

    • Dissociation apraxia refers to the inability to pantomime to command, despite the ability to imitate and use objects perfectly.

    • Although the term ideational apraxia has been used to describe a variety of apraxias, its current meaning is an inability to correctly sequence a series of acts that lead to a goal (such as making a sandwich).

    • Patients with conceptual apraxia show errors in trying to use or pantomime using tools correctly, such that they may show hammering when asked to demonstrate the use of a screwdriver. Many of these patients also show deficits in semantic memory, having lost the meaning of these items.

  • Rigidity: An increase in muscle tone causing resistance to movement of the joint.

  • Akinesia : An inability to initiate movement owing to difficulty selecting and/or activating motor programs.

  • Dystonia: Occurs when sustained muscle contractions cause abnormal postures or movements.

  • Asterixis: A sudden involuntary loss of tone in a muscle group.

  • Myoclonus: A brief, involuntary twitching of a muscle group.

  • A jerky postural tremor: A “tremor” typically caused by frequent asterixis and myoclonus.

  • Sensory symptoms: Includes numbness and tingling.

  • Cortical sensory loss: Primary sensory abilities are normal, but there are deficits in the ability to use this information to make appropriate judgments. Patients can feel a touch, distinguish sharp from dull, warm from cold, and so on, but they are unable to identify a coin by feeling it (stereognosis, see ) or a number when it is drawn in their hand (graphesthesia, see ).

  • Visuospatial deficits: Impairment in one or more visuospatial functions such as copying a cube or intersecting pentagons, left/right discrimination, neglect, simultagnosia (difficulty perceiving multiple objects at the same time), or directing limb movement via visual guidance. (See Chapter 11 .)

  • Neglect: Ignoring one side of space. Often tested by presenting stimuli on both sides of the body simultaneously and ascertaining whether patients ignore stimuli on one side of the body in the absence of a primary sensory deficit. Left neglect is much more common than right. (See Chapter 11 .)

  • Apraxia of speech: Abnormality of speech including slow speaking rate, abnormal prosody (some of the nonlinguistic aspects of speech such as emotion and intonation), and distorted sound substitutions. (See Chapter 9 .)

  • Speech disturbance: The disturbance in speech can include orobuccal apraxia (apraxia of the mouth, lips, and tongue), apraxia of speech, halting and/or effortful speech. (See Chapter 9 .)

  • Executive dysfunction: Impairments in planning, abstraction, problem solving, judgment, working memory, and goal-directed behavior.

  • Behavioral disorder: Symptoms may include apathy, bizarre or antisocial behavior, personality changes, irritability, disinhibition, and hypersexuality. (See Chapter 10 .)

Over time the affected limbs become more rigid, with rapid movements such as pronation/supination and alternating finger tapping becoming impaired. Eventually even passive stretch may not be possible. Dystonia may become prominent, with the hand often becoming a clenched fist or having hyperextension of one or more fingers. Myoclonus is often seen in the fingers, which may increase with sensory stimulation and finger movements. Although all four limbs are commonly involved in the later stages, asymmetry is usually maintained.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here